#USA #Boca Raton #Aesthetic Medicine #AbbVie #Galderma

Understanding the Aesthetic Medicine AI Visibility Index

A recent study conducted by 5W AI Communications has unveiled intriguing insights into the landscape of aesthetic medicine by analyzing AI citations that direct patients towards brands and medical providers. The 2026 Med Spa & Aesthetic Medicine AI Visibility Index serves as a pivotal reference for understanding how patients engage with aesthetic treatment options through modern AI platforms such as ChatGPT and Google AI.

Key Findings of the Index

The findings of this new Index illuminate the dominance of pharmaceutical giants AbbVie and Galderma, who collectively control 80% of the AI citation share in aesthetic medicine. AbbVie, renowned for its popular products including Botox and Juvederm, commands a substantial 47% of the AI citations, while Galderma—known for Dysport and Restylane—follows closely with 33%. The remaining 20% of citations are divided among other competitors, including Merz Aesthetics and Revance.

One striking statistic revealed is that Botox achieved a phenomenal score of 95 out of 100, establishing it as the highest-rated single brand in AI citation rankings. This level of recognition is not coincidental; Botox, Juvederm, and the term ‘aesthetic medicine’ are often interchangeably used throughout various AI-generated responses concerning wrinkle treatments.

Interestingly, online platforms like RealSelf, which provides patient reviews, scored an impressive 86—outperforming individual med spa reviews and manufacturer ratings in the field. This demonstrates how patient-centered platforms capture consumer interest in a way that leads even beyond the reach of the biggest pharmaceutical companies.

The Role of Competition

As the market for aesthetic treatments continues to grow—estimated at $25 billion in the U.S. and expanding at around 15% annually—it’s noteworthy that about 12,000 facilities are currently vying for a piece of this lucrative pie. The Index draws attention to Daxxify, a product by Revance launched recently in 2023, which is already ranking within the top ten despite being a newcomer in an established field.

Furthermore, LaserAway—the nation's largest med spa chain—ranks #7 in citation share, emphasizing the vital role that larger, well-branded entities play in shaping public perception through effective marketing strategies. However, the rankings reveal a significant gap: While the top 25 brands command 95% of AI citations, nearly 11,500 independent med spas share the remaining 5%. This ‘Visibility Gap’ spotlights the challenges independent practitioners face in reaching patients through these AI-driven channels.

The Implications for Aesthetic Brands

As Ronn Torossian, founder of 5W AI Communications, states, "Citation share is the new market share"—highlighting that visibility in digital spaces has become as important as traditional marketing. Brands that fail to secure substantial AI presence risk being overlooked by potential patients who rely heavily on automatic AI responses to shape their treatment decisions.

Methodology Behind the Index

To compile this data, 5W utilized a set of 65 standardized queries targeting potential patient concerns and interests across multiple AI platforms. These queries addressed various aspects of aesthetic treatment, such as safety, costs, and procedural outcomes. Each component was analyzed based on citation frequency and authority, reflecting an understanding of consumer behavior in the context of modern aesthetics.

Future of Aesthetic Medicine's Visibility

The 2026 Med Spa & Aesthetic Medicine AI Visibility Index is not just a snapshot of the current landscape; it serves as a critical tool for brands keen on optimizing their presence in this evolving market. As AI continues to play a transformative role in healthcare decision-making, it is clearly crucial for aesthetic brands to understand and adapt to this new reality to enhance their visibility and capture potential patient interest. For further details, access the full index on 5W's website.